Summary
A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type 2 diabetes.

The purpose of the guideline is to assist medical, nursing and nuclear medicine staff to prepare and manage people living with diabetes undergoing a PET scan. This guideline is for the provision of advice only and does not replace clinical decision making in individual patients or specific protocols adapted for individual centres.

• Download the Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024) – PDF
• Download the Internal Medicine Journal position paper Joint Australian Diabetes Society/Australian and New Zealand Society of Nuclear Medicine procedure guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (March 2026) – PDF